A new look at osteoporosis outcomes: The influence of treatment, compliance, persistence, and adherence

被引：27

作者：

Badamgarav, Enkhe ^{[1
]}

Fitzpatrick, Lorraine A. ^{[1
]}

机构：

[1] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

MAYO CLINIC PROCEEDINGS | 2006年 / 81卷 / 08期

关键词：

D O I：

10.4065/81.8.1009

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

收藏

页码：1009 / 1012

页数：4

相关论文

共 27 条

[1]

Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy [J].

Björn, I ;

Bäckström, T .

MATURITAS, 1999, 32 (02) :77-86

[2]

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].

Black, DM ;

Cummings, SR ;

Karpf, DB ;

Cauley, JA ;

Thompson, DE ;

Nevitt, MC ;

Bauer, DC ;

Genant, HK ;

Haskell, WL ;

Marcus, R ;

Ott, SM ;

Torner, JC ;

Quandt, SA ;

Reiss, TF ;

Ensrud, KE .

LANCET, 1996, 348 (9041) :1535-1541

[3]

The impact of compliance with osteoporosis therapy on fracture rates in actual practice [J].

Caro, JJ ;

Ishak, KJ ;

Huybrechts, KF ;

Raggio, G ;

Naujoks, C .

OSTEOPOROSIS INTERNATIONAL, 2004, 15 (12) :1003-1008

[4]

CAN WE IMPROVE COMPLIANCE WITH LONG-TERM HRT [J].

COOPE, J ;

MARSH, J .

MATURITAS, 1992, 15 (02) :151-158

[5]

Persistence with bisphosphonate treatment for osteoporosis: Finding the root of the problem [J].

Cramer, JA ;

Silverman, S .

AMERICAN JOURNAL OF MEDICINE, 2006, 119 (04) :12S-17S

[6]

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis [J].

Cramer, JA ;

Amonkar, MM ;

Hebborn, A ;

Altman, R .

CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (09) :1453-1460

[7]

Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial [J].

Delmas, PD ;

Ensrud, KE ;

Adachi, JD ;

Harper, KD ;

Sarkar, S ;

Gennari, C ;

Reginster, JY ;

Pols, HAP ;

Recker, RR ;

Harris, ST ;

Wu, WT ;

Genant, HK ;

Black, DM ;

Eastell, R .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3609-3617

[8]

Adherence and persistence associated with the pharmacologic treatment of osteoporosis in a managed care setting [J].

Downey, Timothy W. ;

Foltz, Susan H. ;

Boccuzzi, Stephen J. ;

Omar, Mohamed A. ;

Kahler, Kristijan H. .

SOUTHERN MEDICAL JOURNAL, 2006, 99 (06) :570-575

[9]

COMPLIANCE WITH LONG-TERM ORAL HORMONAL REPLACEMENT THERAPY [J].

EIKEN, P ;

KOLTHOFF, N .

MATURITAS, 1995, 22 (02) :97-103

[10]

Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis [J].

Harris, ST ;

Watts, NB ;

Li, Z ;

Chines, AA ;

Hanley, DA ;

Brown, JP .

CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (05) :757-764